FDA PMA
FDA Class 3
Approved
🇺🇸 United States
Heart-Valve, Non-Allograft Tissue
PMA: P170006
·
Supplement: S025
·
Decision Jan 31, 2024
Classifications
1
FEI Numbers
19
Registration Numbers
19
Basic Information
- Device Name
- Heart-Valve, Non-Allograft Tissue
- Trade Name
- Avalus Ultra Bioprosthesis
- PMA Number
- P170006
- Supplement Number
- S025
- Device Class
- FDA Class 3
- Product Code
- LWR
- Generic Name
- heart-valve, non-allograft tissue
- Medical Specialty
- Unknown
- Advisory Committee
- Cardiovascular
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- January 31, 2024
- Date Received
- September 1, 2023
- Supplement Type
- Normal 180 Day Track
- Supplement Reason
- Change Design/Components/Specifications/Material
- Expedited Review
- N
Advisory Committee Statement
Approval for design modifications to the Avalus Bioprosthesis device including the addition of a radiopaque marker and changes to the stent base design and sewing ring. The device, as modified, will be marketed under the trade name Avalus Ultra Bioprosthesis.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| LWR | Heart-Valve, Non-Allograft Tissue | FDA class 3 | Unknown |